List view / Grid view

Dr Michael Fiebig (Chief Scientific Officer at Absolute Antibody)

 

article

Antibodies come full circle: biopharma back at the bench

Recombinant antibody technology is redefining research standards - bringing biopharma-grade…

31 July 2025 | By

Recombinant antibody technology is redefining research standards - bringing biopharma-grade precision, consistency, and customisation to the lab. Discover how advances like Fc engineering and chimerisation are accelerating progress from basic discovery to clinical insight.